Bivalirudin for pediatric procedural anticoagulation: a narrative review
KL Zaleski, JA DiNardo, VG Nasr - Anesthesia & Analgesia, 2019 - journals.lww.com
Abstract Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …
Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.
KL Zaleski, JA DiNardo, VG Nasr - Anesthesia and Analgesia, 2019 - europepmc.org
Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …
Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review
KL Zaleski, JA DiNardo… - Anesthesia and …, 2019 - pubmed.ncbi.nlm.nih.gov
Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …